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Abstract
Multicellularity evolved independently in multiple lineages, yielding organisms with a
wide range of adult sizes. Building an intact soma is not a trivial task, when dividing
cells accumulate damage. Here, we study ‘ontogenetic management strategies’, i.e. rules
of dividing, differentiating and killing somatic cells, to examine two questions. First, do
these rules evolve differently for organisms differing in the target mature body size, and
second, how well a strategy evolved in small-bodied organisms performs if implemented
in a large body – and vice versa (‘large’-evolved strategies in small bodies). We model
the growth and mature lifespan of an organism starting from a single cell and optimize,
using a genetic algorithm, trait combinations across a range of target sizes, with seven
evolving traits: 1) probability of asymmetric division, 2) probability of differentiation
(per symmetric cell division), 3) Hayflick limit, 4) damage response threshold, 5) damage
response strength, 6) number of differentiation steps, 7) division propensity of cells rel-
ative to ‘stemness’. Some, but not all traits, evolve differently depending on body size:
large-bodied organisms perform best with a smaller probability of differentiation, a larger
number of differentiation steps on the way to form a tissue, and a higher threshold of
cellular damage to trigger cell death, than small organisms. Strategies evolved in large
organisms are more robust: they maintain high performance across a wide range of body
sizes, while those that evolved in smaller organisms fail when attempting to create a large
body. This highlights an asymmetry: under various risks of developmental failure and
cancer, it is easier for a lineage to become miniaturized (should selection otherwise favour
this) than to increase in size.
Keywords: life history | Peto’s paradox | telomere | apoptosis | tissue organisation | stem cells | differen-
tiation
Introduction
Multicellularity allows an organism to divide tasks between cells, creating a complex
soma with a much wider range of functions than single-celled organisms can achieve
(Grosberg and Strathmann, 2007; Knoll, 2011). It also permits large body size, which
may help in predator avoidance (Boraas et al., 1998; Kapsetaki and West, 2019) and be
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subject to other types of selection to become large, including metabolic scaling (White
et al., 2019) and intraspecific competition (Kingsolver and Pfennig, 2004; Pettersen et al.,
2015). However, creating and maintaining the soma of a multicellular organism is not a
trivial task. This requires cooperation between their individual cells, where somatic cells
forgo passing their genetic material to the offspring, and they divide only to maintain
organismal functions. From a single somatic cell’s perspective, if the benefits of cooperat-
ing outweigh self-replicating, this can still be advantageous (Goldsby et al., 2014; Libby
et al., 2016). But even if somatic cells ‘aim’ to cooperate, they inherit their genomes
from germline cells that have unlimited dividing potential, and the adjustments required
to make cells a differentiated part of a somatic tissue may not always function flawlessly.
Uncontrolled growth (cancer) is one problem (Aktipis et al., 2015), and since tumours
typically only arise when several mutations have occurred in the same cell lineage, the
number of ‘permitted’ cell divisions has evolved to be limited (Sager, 1991; Campisi, 2013;
Maciejowski and de Lange, 2017). Together with other aspects of somatic maintenance,
such as damaged cells being recognized and entering cell cycle arrest or undergoing pro-
grammed cell death (Fuchs and Steller, 2011; Campisi, 2013), and the hierarchical tissue
organization (Dere´nyi and Szo¨llo˝si, 2017) that maintains some cells in a stemlike state
while differentiates others, these rules reflect what we call the ‘ontogenetic management
strategy’ of an organism’s cells.
There are good reasons to suspect that such a strategy is not of a ‘one size fits all’ type,
i.e., that ontogenetic rules evolve to be different depending on the target body size at
maturity. Despite the great range of body sizes in nature, many multicellular organisms
go through a single-cell stage. The resulting high relatedness between cells appears to
be a way to improve cooperation between individual cells (Queller, 2000; Grosberg and
Strathmann, 2007; Fisher et al., 2013; Bastiaans et al., 2016), but it also means that
larger organisms need to do more cell divisions to reach their mature size. Moreover, once
mature, the adult size needs to be maintained, balancing the cell turnover that occurs
throughout life (Fuchs and Steller, 2011; Galluzzi et al., 2018); again, larger organisms
maintain a larger cell population. Mature body size is also not the only axis of variation
that is likely to matter for the optimal strategy: extrinsic mortality can also matter
(Boddy et al., 2015). Organisms that face a high risk of extrinsic mortality need to ensure
that they mature fast enough to reproduce before they die. Low-mortality scenarios in
turn give prolonged opportunities to reproduce (accumulating fitness iteroparously), but
these can only be realized by organisms with robust enough bodies that last a sufficiently
long time.
Empirical evidence for variation in traits that comprise the ontogenetic strategy can
be found in both comparative ageing and oncology literature. Already in the mid-20th
century, Hayflick and Moorhead observed that somatic cells could only divide a finite
number of times, termed the ‘Hayflick limit’ (Hayflick and Moorhead, 1961; Hayflick,
1965; Shay and Wright, 2019). This limit is related to telomere length and telomerase
expression, and both affect cancer- and senescence-related processes, with e.g. telom-
erase expression observed in most human tumours (Kim et al., 1994), allowing tumour
cells to divide without hitting the Hayflick limit (Blasco, 2005; Shay and Wright, 2019).
Comparative studies have revealed correlations between body size and/or lifespan and
telomerase activity and telomere length (Seluanov et al., 2007; Gomes et al., 2011), a pat-
tern also predicted by theory (Risques and Promislow, 2018). For example, the finding
that telomerase expression is repressed in somatic tissues of humans and larger mammals
(Kim et al., 1994; Gomes et al., 2011) fits in well with the idea that telomerase expression
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is not a risk-free way to increase lifespan. It enables cell lineages to persist for longer,
but may open the door to cancer. Again, this may be a problem for large organisms in
particular, as they need many cells for a long time, while careless attempts to do this,
e.g. via increasing the Hayflick limit, may end their lives with cancer instead.
The finding that cancer incidence does not scale with body size despite an increased
number of cell divisions (Peto’s paradox: Peto et al., 1975) has led to a quest to find
the adaptations that mitigate cancer risk as body size increases (Caulin and Maley,
2011). In addition to telomere management, potential adaptations include stronger DNA
damage response (for a comparison of elephants and humans see Abegglen et al., 2015),
or increasing the number of differentiation levels from the stem cell to the terminally-
differentiated cells (theory: Dere´nyi and Szo¨llo˝si, 2017). The precise manner in which
cells populate these degrees of differentiation has implications for controlling damage
accumulation in tissues and consequent cancer risk (e.g. Shahriyari and Komarova, 2013),
as well as tissue homeostasis and senescence-related processes (Liu et al., 2019).
Our aim is to combine the above considerations in a single model. The various mecha-
nisms listed above do not act in isolation, instead, they orchestrate ontogeny and survival
in concert with each other. We model organismal growth and subsequent mature lifes-
pan, assuming throughout that the organism starts its life as a single cell and reaches
its target mature body size through divisions and differentiations (unless it dies before-
hand through extrinsic mortality or ‘mismanagement’ of its own growth). We consider
the trade-offs inherent in any ontogenetic strategy: delaying death via one cause (e.g.,
by increasing the Hayflick limit) may hasten the probabilistic death from other causes
(e.g., increased cancer risk). The interacting causes of death allow us to quantify the
expected fitness of any given ontogenetic management strategy. We specifically investi-
gate whether a genetic algorithm finds the same solutions across different body sizes, or
larger bodies require fundamentally different ontogenetic management than small bodies.
Some traits turn out to be more body size specific than others, such that as a whole,
multiple alternative combinations of traits may yield a well-functioning soma for a given
body size. Finally, we investigate how the cell-management strategies that evolved with
specific body sizes fare across a wider range of body sizes. Here, a clear asymmetry
emerges: ontogenetic management strategies that evolved in smaller organisms generally
fail to perform in large organisms, leading to frequent premature death. The converse
is not true: strategies adapted to a large body size fare reasonably well across all body
sizes.
Materials and Methods
Model overview
Our model tracks the number and state space of all the cells of an organism (see Fig.1
for an overview) from zygote to organism-level death. Deaths occur stochastically, thus
the success of a strategy is evaluated by running independent realizations of the growth
and lifespan that results from a specific ontogenetic strategy. The ontogenetic strategy
has a total of seven components, all evolving within a prespecified plausible range (see
Table 1 for permitted ranges of values): the Hayflick limit (the number of divisions a
cell can go through), denoted H; the number of levels to terminal differentiation, T ;
the probability that a cell division is asymmetric, P ; the differentiation probability in
symmetric divisions, Q; the division propensity of each differentiation level (relative to
the previous level), X; the DNA damage response threshold, A; and the probability that
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Figure 1: The model structure. In panels (a) and (b), rows represent the number of di-
visions a cell lineage has accumulated (since the zygote). As cells divide, their telomeres
shorten, which moves them down to the next row. Any cell that reaches the last row is
removed (loss of telomeres; blue in both panels). The two other states are (a) differen-
tiation towards tissue (reached at terminal differentiation, T ) and (b) mutations causing
DNA damage. Unlike the shortening of telomeres, these two aspects happen probabilis-
tically, with the organism controlling differentiation via its ontogenetic strategy (c), and
mutations occurring with probability c in the new cells. A cell that has reached the final
column (purple) in (a) cannot divide further but contributes to somatic function; a cell
that reaches the final column (red) in (b) becomes oncogenic and kills the organism. (d)
Cellular turnover occurs as a result of various processes of cell removal: telomere loss,
DNA damage-related cell death, or a baseline turnover rate ν. (e) The organism can die
due to various causes related to extrinsic mortality, failed ontogenetic management of its
cell population, or cancer.
a cell is killed upon DNA damage detection, S.
The individual organism is modelled as a population of cells. At each time step, the
organism experiences a cell number deficit D if it has fewer terminally differentiated cells
than its body size target (details on how D is determined are given below). Filling this
deficit requires cells to divide, and this can change the state of the participating cells in
three different ways. We do not give spatial coordinates or specific tissue functions to
cells, instead cells may differ from each other in three distinct (but possibly covarying)
ways: how differentiated they are, how many divisions they are a result of (since the
zygote state), and how damaged they are. The variables H to S, above, interact to
determine the transition probabilities between these states. We give a brief description of
the three-dimensional state here, and describe the actual interactions between variables
and movements in state space later.
First, cells differ in their level of differentiation (horizontal axis in Fig.1a), modelled
as integer-valued levels from 0, the zygote, to T , a cell that contributes to tissue. All
non-terminally differentiated cells are hereafter collectively called ‘stemlike cells’ (with
total number Nstemlike), which include the actual stem cells (level 0, N0) as well as the
more differentiated transit-amplifying cells, NTAC, that still have division potential (levels
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Table 1: Traits that form the ontogenetic strategy, together with the possible range
within which evolution can take place (new mutations occur within the prespecified
range)
Symbol Trait Range
P Probability that a cell division is asymmetric real numbers between 0.0 and 1.0
Q Differentiation probability in symmetric divisions real numbers between 0.0 and 1.0
T Number of differentiation steps integers between 3 and 50
X Division propensity of each differentiation level real numbers between 0.01 and 200
(relative to the previous level)
S Percent of cells killed upon damage detection real numbers between 0.0 and 1.0
A Damage response threshold real numbers between 0 and K*
H Hayflick limit (the maximum permitted integers between 5 and 500
number of cell divisions)
* K is the number of oncogenic steps that, if completed, result in cancer
1 to T–1). Terminally differentiated cells (level T , Ntissue) perform somatic functions and
cannot be chosen to divide further. The value of T evolves, i.e. is part of the ontogenetic
strategy.
The second component of a cell’s state is the number of times the cell has divided
from the zygote state (shown vertically in both Fig.1a and 1b; note that the entire cell
state structure is three-dimensional). Values range from 0 (the zygote) to H (the Hayflick
limit: Hayflick and Moorhead, 1961; Hayflick, 1965). Although we do not track declining
telomere length explicitly (in terms of base pairs), a cell moving along this axis can be
interpreted as losing telomere length, such that cells that have reached level H have too
short telomeres to divide further. These cells are removed whether or not they are also
terminally differentiated. The value of H itself corresponds to telomere length at the
beginning of life (specifying the maximum number of cell divisions permitted for any cell
lineage thereafter), and is part of the ontogenetic strategy.
The third component of cell state (horizontal axis in Fig.1b) tracks the accumu-
lated damage in a cell, corresponding to oncogenic steps termed ‘mutational hits’ or
‘rate-limiting steps’ in models (Nunney, 1999; Calabrese and Shibata, 2010; Kokko and
Hochberg, 2015). We track damage with integers from 0 to K, with 0 being the state
without any oncogenic damage. The maximum tolerable damage, K, is not an evolving
part of the ontogenetic strategy, but a constraint that organisms must evolve to deal
with: once an organism has at least one cell of damage level K, it is assumed to die from
cancer.
Cancer, however, is not the only way for an organism to die (Fig.1e). Life can end
with 1) not having stemlike cells to keep dividing to maintain its differentiated cells, 2)
falling below a certain number of terminally-differentiated cells after maturation, 3) losing
all cells before maturation, 4) cancer, and 5) extrinsic mortality (parameter µ) (Table 2).
We further divide the death cause 1 into pre- and post maturation, to distinguish between
developmental (1-a) and somatic maintenance failures (1-b). Some of the causes of death
in this list, such as failure of the developmental program to produce any terminally-
differentiated cells, are less likely than others to be observed in real organisms. However,
since our aim is to investigate which ontogenetic strategies work (i.e. can produce an
organism that can mature and reproduce) and which do not, we need to explicitly track
deaths due to failures to achieve a functioning soma in the first place.
A zygote begins its life in the state 0, 0, 0 (no differentiation, no divisions yet, no dam-
age accumulation). We track the subsequent number of cells in the entire 3-dimensional
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Table 2: Death causes for an individual organism
Cause Criterion Number in the text
Depleting stemlike cells pre- or post-maturation Nstemlike = 0 1-a & 1-b
Not having enough tissue cells (after maturity) Ntissue < M × 0.8 2
Losing all the cells before reaching maturation N = 0 3
Cancer at least one cell 4
at damage level K
Extrinsic mortality (µ) t ≥ – ln 0.001/µ 5
state space over time (the age of the organism) as the fourth dimension. At death, we
record the fitness of the organism. No fitness accumulates before reaching mature size
(a parameter, M , that we vary over 2 orders of magnitude); afterwards, each time step
contributes to cumulative fitness. Since only terminally differentiated cells are assumed
able to perform useful functions for the whole organism, we model the per-step fitness
gain as the proportion of terminally differentiated cells (out of all cells) that the organism
currently has. This reflects the biologically plausible assumption that cells that are not
terminally differentiated impose maintenance costs while not yet contributing to somatic
function. Maintaining an excessive population of such cells therefore reduces fitness. The
expected fitness of the ontogenetic strategy (as opposed to a single realization, i.e. an
individual life) is obtained by rerunning this process multiple times.
Growth, differentiation, and fitness
Here we describe the procedures that create a single run of an organism’s life. Starting
from a single cell (zygote), the organism grows via division and differentiation of its cells.
It matures when it has reached a predefined size called the maturity threshold M defined
as a sufficient number of terminally differentiated cells. We track an individual’s fitness
accumulation until tdeath where continuing life is not possible for death reasons 1 to 4
listed in the Table 2, or when it has reached an age tend = – ln 0.001/µ, an age that is
only reached with probability 0.001 when extrinsic mortality (the fifth cause of death)
equals µ. If the organism reached maturity before dying, its age at this point is recorded
as tmaturation. Thereafter, the expected fitness is computed as a weighted sum of the fitness
gain.
W =

0 if maturity was not reached∑tdeath
t=tmaturation
w(t) if tdeath ≤ tend∑tend
t=tmaturation
w(t) otherwise
(1)
Here w(t) = Ntissue(t)
N(t)
e−µt, where Ntissue(t) gives the numbers of terminally differenti-
ated cells at age t, N(t) is the total number of cells (= Ntissue(t) + Nstemlike(t)), and the
last term is the probability that the organism has escaped extrinsic mortality up to age
t.
To find w(t) and the times of maturity and death, we need to describe how the
ontogenetic strategy spreads new cells into the state space. We assume that an organism
grows towards the maturity threshold before it has reached this size, and aims to maintain
the number of terminally differentiated cells thereafter (which requires compensating for
cells that have died either because of a baseline cell turnover ν, see below, or because
of being killed as part of the ontogenetic strategy). Thus, both before maturity and
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afterwards, the organism begins a time step by measuring the difference between the
target number of terminally differentiated cells (M) and its current number (Ntissue).
The deficit D is then defined as D = k(M −Ntissue), rounded up to the nearest integer,
where the multiplication with a constant k makes growth before maturity approximate a
von Bertalanffy trajectory (Karkach, 2006).
In case of a positive deficit, up to D stemlike cells will divide. If D ≤ Nstemlike, the
number of dividing cells is D, which makes the deficit vanish. If D > Nstemlike, then all
Nstemlike cells divide, and the deficit diminishes. In both cases, D will be calculated anew
in the next time step. If there is an excess of stemlike cells to choose from (the first case),
the precise identity of cells chosen for division follows component X of the organism’s
ontogenetic strategy, in the following manner.
Stemlike cells occur in different states of differentiation 0, 1, . . . , T–1. Ontogenetic
strategy component X is defined as the relative division propensity of a given level of
differentiation compared to the previous one (X > 1 means that propensities increase
with level of differentiation). Cells are chosen (without replacement) to divide with
relative propensities that are proportional to X i, where i is the cell’s current degree of
differentiation, until the appropriate (see above) number of cells have been chosen. A
cell’s position along the H or K axis does not directly impact its likelihood of becoming
a dividing cell, though patterns of covariation are likely to arise because cells far on their
path to full differentiation are also likely to have progressed further from the 0 state along
these axes too. Thus if X is high, divisions use stem cells sparingly, which also means
that divisions occur more commonly in cells that have already incurred some damage.
Once the state-specific numbers of dividing cells is known, each division is performed
taking into account strategy components P and Q (Fig.1c). The division occurs asym-
metrically with probability P , in which case one daughter cell is placed into the soma
one step further along the differentiation axis while the other daughter cell does not
change in its level of differentiation (for placements along the other axes, see below).
With probability 1−P , the cell divides symmetrically, and in this case component Q of
the strategy is also relevant. Each of the two daughter cells enters the soma as either
one step more differentiated than the parent (with probability Q, applied independently
for both daughters) or at the same level of differentiation as the parent (with probability
1−Q, interpretable as replenishment of the pool of stemlike cells). Thus, as a whole, with
probability (1−P )Q a division occurs symmetrically and yields in two daughter cells that
are both more differentiated than their parent, whereas with probability (1−P )(1−Q) it
yields in two cells at the identical level of differentiation as the mother cell, and finally
with probability P the division produces one daughter that is more differentiated than
the parent and another daughter that remains at the original differentiation level.
We also need to specify the positions of the new daughter cells along the H and K
axes. Since the H axis tracks the number of cell divisions, the new location along this
axis is always one step further than the old location (and since only stemlike cells, up to
H–1, can be chosen to divide). Regarding DNA damage, each new daughter cell can be
at the same location along the K axis (with probability 1−c) or with an increased level
of DNA damage, i.e. one step further along the K axis (probability c).
At the end of a division round, we apply various sources of mortality to cells (Fig.1d).
Parental cells have at this point become two daughter cells, necessitating removing the
original parent from the soma. Cells that have reached the Hayflick limit (state H) are
also removed. Furthermore, the ontogenetic strategy has two components, A and S,
that aim to remove damaged cells (cells that are far along the K axis regardless of their
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position along other axes), but we assume that the recognition of damage is imperfect.
A proportion S of cells with a +  ≥ A are killed, where a is a cell’s true location along
the K axis and an error term  ∼ N(0, 0.5) reflects the difficulty of determining precisely
how damaged a cell is. Since recognized damage is a real number (not restricted to
integer values), we also allow A to take real number values. The organism cannot evolve
a smaller , but it can evolve a suitable A, with a clear trade-off: a low A is good for
reliable removal of all damage, but a large number of healthy cells will then be removed
too, depleting the pool of stemlike cells potentially too quickly. Finally, any of the cells
that survive the above mortality risks die with probability ν, reflecting baseline cellular
mortality (cell turnover), applied independently to each cell.
Finding the optimal strategies using a genetic algorithm
The multidimensionality of the fitness landscape (seven evolving traits) creates a challenge
for any optimization procedure, and we thus implement a genetic algorithm to seek for
the best combinations of traits. We begin the optimization procedure with a population
of 100 ancestral ontogenetic strategies, initializing each of the seven components (P , Q,
T , X, S, A & H, Table 1) by picking from uniformly distributed ranges (the relevant
ranges for each variable are listed in Table 1). Then, we estimate the fitness of each
strategy (W , eq. 1) 10 times, but to speed up the optimization, we stop evaluating the
fitness of a strategy if the first four estimates are zero, but nevertheless keep it in the
population (with fitness estimated as zero) for the subsequent genetic algorithm run. For
all other strategies, we estimate mean fitness (Ŵ ) as the average value of W across the
10 runs. This set forms the initial population of candidate strategies.
We next start the genetic algorithm, consisting of numerous rounds. In each round
we first rank the strategies with respect to their Ŵ and pick 10 as ‘potential parents’ (in
the sense of a genetic algorithm). To avoid the danger of populations becoming stuck on
a local fitness peak, which results easily if the algorithm is allowed to focus on the 10
best strategies that each recombine with each other and thus become similar, we choose
10 equally spaced strategies from the population (i.e. 1st, 12th, 23rd,...,100th). We
then proceed to form two ‘parents’ out of the potential parents. The probability that a
strategy is selected as the first parent is proportional to its Ŵ . Once the identity of the
first parent is known, we mutate it as follows: we create a novel random strategy within
bounds shown in Table 1 and calculate the difference in trait values between the novel
strategy and the parent strategy. The parent’s trait values are then shifted somewhat
toward the new random strategy: for each component of the strategy, the new value is
xnew = (1–s)xold + sxnovel, where s ∼ Gamma(0.25, 0.1) truncated between 0 and 1. The
parameters of the gamma function (shape=0.25, scale=0.1) are chosen to make sure that
mutations generally happen with small steps, with occasional bigger jumps. Traits T and
H are thereafter rounded to the nearest integer.
Genetic algorithms typically use a stylized version of crossovers of chromosomes. We
use crossover by assuming that each ontogenetic strategy is represented with a string
(formed by traits P -Q-H-A-S-T -X) analogous to a chromosome. We pick a random
mid-point (between any two traits) and recombine the chromosomes of two parents, by
picking a second parental strategy from the remaining pool of potential parents (this
parent is chosen randomly, i.e. without taking into account relative fitness, and also is
not mutated). In the resulting ‘offspring’ strategy, all the values up to that mid-point
comes from one of the parents (either the newly mutated one, or the second parent, with
50% probability for either option), and the rest from the other parent.
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The offspring strategy’s fitness Ŵ is evaluated using the same procedure as was done
for the parental generation, except now we drop this offspring (and go back to creating
a new offspring with the procedure above) if at any point after the first four of the
ten realizations the mean of its W values fall below the parental population’s best Ŵ
(as such an offspring is unlikely to be a winner). If the offspring’s Ŵ based on all 10
realizations exceeds the entire population’s best-ranked strategy’s Ŵ , it becomes the new
‘best strategy’ and the lowest-performing strategy is removed from the population. In
the alternative case where the offspring’s Ŵ is lower than the best, but still better than
the worst-performing Ŵ present in the population, we add the offspring strategy to the
population as a potential parent that could be picked in the next rounds (and again
remove the worst one).
We stop the genetic algorithm if no new ‘best strategy’ is found for 300 rounds. We
run the genetic algorithm four times independently for each maturity threshold M , from
different initialization points of the original population.
Results
Optimized life histories reached much higher lifetime fitness at small than at large body
sizes (Fig.2a). While surprising at first sight, note that our model did not give large
organisms any of the advantages often associated with body size (Kingsolver and Pfennig,
2004). We therefore do not examine selection to become large per se, but ask how
organisms deal with the increased difficulties that creating a larger body entails. A
major challenge is that reaching maturation size takes more time if the required size is
larger (Fig.2b). Meeting this challenge requires changing some, but not all, components
of the ontogenetic strategy in a systematic manner. The probability of differentiation (Q)
declines with body size (Fig.2d), while the number of levels to terminal differentiation
(T ) increases (Fig.2e). Also, at larger body sizes, the damage response threshold (A) was
never found to be low, whereas low body sizes can be viable with a range of values for A
(Fig.2h).
The remaining four traits (P , X, S, and H; Fig.2c, f, g, and i, respectively) did not
show as clear patterns related to body size. There are two potential explanations: that
the fitness landscape is very flat with respect to these traits, or that the traits matter for
fitness, but occur in the form of coadapted gene complexes (Sinervo and Svensson, 2002;
Schwander et al., 2014). In the latter case, an overall ‘shotgun-like’ pattern (Fig.2c, f,
g, and i) has more structure than is apparent at first sight: a rugged multidimensional
fitness landscape may produce high fitness at particular combinations of trait values,
rather than peaking at a single value for each trait independently of the six other traits.
For example, the lower values of Q in Fig.2d associate with the higher P in Fig.2c. When
symmetric divisions contribute less to tissue differentiation (a low Q), an organism might
not suffer if it resorts to more asymmetric divisions (a high P ); at lower Q, P will matter
more (Fig. S1). We tested for the ruggedness of the landscape by using the outcomes
of optimizing the ontogenetic strategy four times independently (from different starting
points). In case of coevolved gene complexes, creating a new strategy by changing one
of the seven evolved components to the outcome of a parallel optimization (for the same
body size) should reduce fitness, which we found to be the case (Supplementary material).
We next ask if evolved ontogenetic strategies form constraints for evolving a different
body size: can a strategy that evolved at a small body size reach high fitness if imple-
mented in a life history with a larger maturation size; and is the reverse true (from large
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Figure 2: Properties of optimized ontogenetic strategies across 21 logarithmically spaced
body sizes. Data refer to the best strategy at the end of each optimization procedure, with
all four independent runs of the optimization procedure depicted for each body size: (a)
mean fitness Ŵ , (b) mean maturation time tmaturation, (c-i), the seven different components
of the ontogenetic strategy as indicated on each y axis. All solutions are derived with
extrinsic mortality µ = 0.01, per-division damage risk c = 0.01, cell turnover ν = 0.0001,
number of oncogenic steps K = 3, and growth parameter k = 0.05.
to small body sizes)? Smaller organisms might fail to operate for long enough if growth
to become large (which takes time) is now required. Reciprocally, strategies evolved in
larger organisms might be expected to fail if their slow way of forming tissues (low Q,
and many levels to full differentiation, T ) means that they are not ‘ready’ when maturing
at small size. We found clear evidence for the first type of failure (from small to large)
but not the second (Fig.3); strategies evolved in larger organisms were relatively robust
to changes in body size, allowing organisms of the entire tested size range to grow to
maturation. Interestingly, the independent parallel optimizations for the ‘evolved while
small’ strategies varied in the range of size increases that they tolerated (for particularly
clear cases see Fig.3b). Thus, while performing equivalently when small, some coadapted
combinations permit size increases much better than others.
The causes of death were different across the examined body sizes. Optimized strate-
gies (Fig.4a) typically manage the soma well enough so that no other cause of death than
extrinsic mortality occurs until very few individuals are alive (due to extrinsic mortality).
In the rare cases where an optimized strategy dies from other causes, then the cause
relates to running out of stem cells at small body sizes, and to cancer at large body sizes.
However, if a small organism attempts to grow larger (than during its evolutionary past
10
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
perpetuity.
this preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in 
The copyright holder for. http://dx.doi.org/10.1101/2019.12.16.877118doi: bioRxiv preprint first posted online Dec. 16, 2019; 
Figure 3: Testing for the performance of ontogenetic strategies evolved at a specific body
size at maturity, M (vertical lines), at 21 logarithmically spaced novel body sizes (novel
maturation size M ′). In (a), all data is depicted together, to show that strategies evolved
under small sizes outperform the others in the range of small sizes (grey), likewise for
medium (red) and large (blue) strategies near their own ancestral sizes. In (b, c, d), the
same data are divided into the four independent runs, yielding four performance curves
that vary considerably in the range of values they can operate in (positive fitness) if tested
in organisms differing from the ancestral size (vertical line). Fitness maintenance is easy
if the novel body size is small (to the left of the vertical lines in c,d) but hard if large (to
the right of the vertical lines in b,c), with the precise shape of the latter pattern being
strategy-dependent. All parameters not given in the figure are as in Fig.2.
that optimized its ontogenetic strategy), the failures typically relate to running out of
stem cells (Fig.4b,c), supporting the interpretation that small organisms do not need as
sophisticated management of the stem cell pool as large ones. Large organisms that turn
small perform well because the now diminished number of cell divisions protect against
cancer, and simultaneously their stem cells do not run out as they were already well
managed; extrinsic mortality then remains the virtually only cause of death (left part of
Fig.4d).
Discussion
Our model integrates seven different aspects of ontogeny (tissue differentiation in the
presence of cancer risk) into a single model, to ask (i) how organisms are expected to
manage their stem (and stemlike) cell populations during tissue differentiation while also
avoiding cancer, and (ii) whether the evolved strategies need to be modified in case
organisms change their body size over evolutionary time.
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Figure 4: Causes of death (failures of the soma) in different scenarios: (a) when the
organism is tested for its own body size (‘novel’ body size equals the one for which
the ontogenetic strategy is optimized), (b,c,d) ontogenetic strategy optimized for small,
medium and large bodies, respectively, tested across various body sizes. Each scenario is
run 40 times (i.e. 10 times for four independently optimized ontogenetic strategies) with
the cause of death reported; ‘no intrinsic cause’ implies that the soma was intact for the
duration of the entire lifespan when it is assumed to end when extrinsic mortality no longer
permits significant survival chances (thus, individuals in this category are predicted to
die due to extrinsic causes). In (a) and (d), failures of the soma were rare, while attempts
to use an ontogenetic strategy in a larger body (b,c) resulted in a relatively systematic
failure to replenish the stem cell population in a sustainable manner. If large body sizes
were instead allowed to use a strategy evolved at large size (a,d), cancer replaces stem
cell depletion as a probabilistically occurring cause of death. All parameter values are as
in figures 2 and 3, unless otherwise indicated. Note that some causes of death (white)
never occurred in this test as it used strategies that already had been optimized; they
may still have occurred at intermediate steps of the optimization procedure.
Regarding our first question, it appears that some aspects of division and differenti-
ation strategies are under stronger selection than others, with the fitness landscape as a
whole showing signs of ruggedness: for a given body size, different initial trait combina-
tions led to different solutions to the same problem while reaching overall similar fitness.
This suggests that organisms of similar size and lifespan, and hence with comparable cell-
management requirements, can grow and survive using a diversity of mechanisms. This
could potentially explain the variation in telomere length or telomerase expression in
mammals, especially in smaller ones (Gomes et al., 2011). While not explicitly modelled
by us, it is intriguing that naked mole rats and blind mole rats counteract cancer risk
using different mechanisms (Seluanov et al., 2018). Since cancer was only one of several
ways to die in our model, our results also highlight the potential for similar ruggedness in
stem cell pool replenishment strategies: there are many ways to succeed in keeping the
stemlike cell population large enough for long enough, such that the remaining challenges
relate to extrinsic mortality only (we here follow a modelling tradition of calling age-
independent mortalities that the organism cannot change as ‘extrinsic’; Abrams, 1993;
Carnes and Olshansky, 1997; Boddy et al., 2015).
Turning to our second question, the body size dependence of the ontogenetic strategy,
we found clear evidence that the strategy requires modification when mature body size
changes. However, this finding comes with two subtleties. Firstly, not all components of
the strategy showed strong relationships with body size. However, the coadaptedness of
strategy components has consequences for the strategies’ robustness when tested in the
context of a novel body size. Specifically, forcing two (or more) independently derived
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strategies to perform at a novel (larger) body size revealed differences in the range of
body sizes that a strategy can still cope with. When a strategy failed when tested in a
larger body, the problems related to running out of stem cells rather than cancer. This is
interesting in the context of Peto’s paradox (Peto et al., 1975; Caulin and Maley, 2011),
which is expressible as ‘all else being equal, more cell divisions should lead to a higher
cancer risk’. In our model, small organisms died due to stem cell depletion if they became
large without being given an opportunity to adapt their ontogeny to their new life history.
The cancer risk reappeared only when they used ‘large’-adapted ontogenetic strategies.
Secondly, there was an interesting asymmetry: Large organisms, which adapted to
their larger size by having a smaller per-cell probability of differentiation, a not too eagerly
applied threshold of killing damaged cells, and many differentiation steps before a tissue
is formed, possessed ontogenetic strategies that also worked well when tested in small
organisms. Although computational limitations prevented us from scaling our study up
to cell numbers involved in large metazoans, we see no reason why such asymmetries would
not continue playing a role at such sizes. Our finding is therefore interesting in the context
of macroevolutionary changes in body sizes, where it is known that miniaturization,
when it happens, appears to proceed much faster than the (as a whole more common;
Kingsolver and Pfennig, 2004) increase in body size over evolutionary time (Evans et al.,
2012). It also fits well with findings of intraspecific variation in humans, where size
increases associate with heightened cancer risk (Green et al., 2011; Nunney, 2018) while
hereditary forms of dwarfism, at least in the context of the so-called Laron syndrome,
appear to offer cancer protection (Laron et al., 2017).
Note that our model should be complemented with additional considerations when
making predictions about rates of evolution. Eco-evolutionary dynamics has features that
we did not take into account: larger organisms tend to have smaller effective population
sizes (with population density as a proxy; Damuth, 1981), which can slow down the
rate of adaptive evolution (Lanfear et al., 2014). We sidestepped such issues as we
simply re-simulated optimized ontogenies for novel body sizes, rather than taking existing
ontogenies as starting points (while beyond the scope of the current paper, we will examine
the consequent phylogenetic inertia in our future work). Generation times also vary with
body size (Martin and Palumbi, 1993); our model is an ‘all else being equal’ investigation
of body size, where time to maturity takes longer for larger maturation sizes, but e.g.
extrinsic mortality does not change. It is interesting to note that our choice to have very
few differences between ancestral and novel conditions (no ecological change apart from
time it takes to mature, which emerges naturally in the model) still led to a prediction
that parallel runs of the optimization procedure will differ in how easily a small-bodied
organism can evolve a larger size. Some ontogenetic strategies collapsed to zero fitness
at much smaller demands to become big, than others. We interpret this finding as a
prediction that some fortuitous small multicellular organisms have preadaptations to
grow over macroevolutionary time, while others face stronger intrinsic constraints. This
adds ontogenetic challenges to the reasons why Cope’s rule, the increase of body sizes in
macroevolutionary lineages, is expected to be a rather stochastic ‘rule’ (see e.g. Liow and
Taylor, 2019).
Some of our findings are, at least at first sight, unexpected. The damage response
threshold A reflects how many mutations are tolerated before a cell is recognized as
damaged and killed (e.g. via apoptosis, or by other cells; we do not specify the exact
mechanism) with probability S. Based on an important study on elephant cells respond-
ing more readily to damage than human cells (Abegglen et al., 2015), one might expect
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A to decrease and S to increase with body size, but such responses did not emerge in our
model. Instead, small organisms could function across a wide range of values for both
A and S, while larger somas were never found to be built with small values of A. This
apparent mismatch between Abegglen et al. (2015) and our results disappears, however,
when taking into account coadaptation between different ontogenetic strategy compo-
nents. Large organisms also evolved to use more steps (T ) to full differentiation, which
also gives cell lineages more cumulative opportunities (in the form of a higher number
of divisions) to accumulate damage. A higher A, when it also associates with a higher
T , therefore does not necessarily mean that fewer cells are observed to be killed in any
phenotype. When T is high, cells have more opportunities to reach a category of damage
that sees them killed. Moreover, since running out of stemlike cells was a real threat in
our model, it appears that this penalizes against very strict ‘quality control’ of cells; no
strategy can succeed if sufficient cell numbers are not maintained, while cancer can at
least probabilistically be avoided (under a multi-step model of oncogenesis; Armitage
and Doll, 1954; Nunney, 1999; Calabrese and Shibata, 2010). These considerations add
to our general message that there are many complementary ways to create a soma of a
certain body size.
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